Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Alopecia Areata Incognita causes sudden hair loss in young females but usually has a better outcome than other types.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Bexarotene gel shows promise as a new treatment for alopecia areata.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

Alopecia areata may be caused by the immune system attacking hair follicles.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The document provides ways to tell alopecia areata from other similar hair loss conditions, using visual checks and specific tests.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Alopecia causes patchy hair loss and can be diagnosed with new techniques; treatments like strong creams and contact immunotherapy can help.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Herbal remedies may help manage alopecia areata hair loss.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Early intervention and patient education are crucial for managing alopecia areata.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Topical tofacitinib is effective and safe for treating alopecia areata.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Alopecia areata affects self-esteem and social life, but new treatments offer hope.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.